The Oncology Institute closed its business combination with DFP Healthcare Acquisitions. DFP shareholders approved the deal Nov. 12.
The Oncology Institute will be led by its existing management team. Shares and warrants begin trading today on the Nasdaq under TOI and TOIIW.
The transaction implies an enterprise value for TOI of $842 million. TOI raised approximately $334 million in cash, including a $275 million PIPE. Approximately $133 million will be retained on TOI’s balance sheet to fund growth initiatives, including de novo clinics and acquisitions. Read more.
